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doi:10.1016/j.ejvs.2009.09.013Abstract Objective: In this histological study, the lateral saphenous vein of the goat was
treated using a laser fibre to which a tulip-shaped, self-expandable catheter had been fixed
to achieve endovenous laser ablation (EVLA). The catheter centres the laser fibre in the vein
preventing direct contact with the vein wall. This study aims to establish whether prevention
of direct contact between the fibre tip and the vein wall prevents ulceration and perforation of
the vein wall and perivenous tissue destruction.
Materials and Methods: Ten lateral saphenous veins were treated, using the tulip catheter, in
goats under general anaesthesia. Ten more veins were treated with a normal bare fibre. We
used a 980 nm diode laser to provide the energy. Postoperatively the veins were removed
immediately, at 10 days and after 3 weeks for histological examination. Destruction of the
vessel wall was measured and perivenous tissue destruction was quantified using a graded
scale.
Results: Ulceration and perforation were prevented when using the tulip catheter. It also
achieved more even vein wall necrosis. Tulip-catheter-treated veins show a transmural vein
wall necrosis in, on average, 80% of the total circumference compared to 64% in bare-fibre
treated veins. Less perivenous tissue destruction was seen with the new catheter (perivenous
tissue destruction scale: tulip catheter: 1.7 vs. bare fibre: 3.8). Three weeks after treatment,
we found regression of the perivenous tissue destruction as the healing process continued.
Conclusions: EVLA using the tulip catheter avoids ulceration and perforation of the vein asso-
ciated with treatment using a bare fibre. It also results in more even circumferential vein wall
necrosis and less perivenous tissue destruction.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.1425060; fax: þ32 51425061.
ac.com (M. Vuylsteke).
ty for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Endovenous laser ablation (EVLA) has become a popular
minimally invasive alternative to surgical vein stripping in
the treatment of saphenous vein reflux. By catheterising
the saphenous vein and introducing a bare fibre into the
lumen, light energy is delivered within the vein to achieve
selective vein wall destruction. This energy is absorbed by
blood and water or by the vein wall. The aim of this tech-
nique is completely to obliterate the incompetent vein
irreversible. Although EVLA has fewer side effects than
conventional saphenous femoral ligation and stripping1e5
resulting in fewer haematomas, less postoperative pain,
paraesthaesia and time off work, the technique still can be
improved. Complications of EVLA include postoperative
ecchymosis, pain, bruising and periphlebitis. These are due
to vein wall perforation and energy dissemination in the
perivenous tissue6,7 and probably arise when the laser fibre
tip frequently contacts the vessel wall during treatment.
This has been observed on ultrasound imaging.8 Tumescent
anaesthesia induces spasm of the vein around the fibre and
can diminish this effect, but does not eliminate the
problem.
When energy is delivered, direct contact between the
fibre tip and the vessel wall may result in ulceration or
perforation of the vein.6,9e11 The tissue effects are
achieved not only by direct absorption of the laser light,
but also by convection of heat energy from the fibre tip
into the surrounding tissue.12,13 Uneven energy applica-
tion during treatment may also be the cause of
a recanalisation.7 So if the laser fibre could be centred
within the vein lumen, complications of EVLA may be
minimised.
A new catheter fixed to the fibre was designed (Fig. 1).
The tulip-shaped, self-expandable distal end at the fibre tip
expands within the vein lumen and pushes the vein wall
away. The shape of the self-expandable tip allows with-
drawal from the fibre and catheter using the conventional
EVLA procedure. This new catheter design was evaluated in
an animal model.Figure 1 Tulip-shaped self-expandPurpose
EVLA performed with an intraluminal fibre-tip centring
device was evaluated in an experimental study in goats. This
study was undertaken to answer the following question: Can
avoidance of direct contact between the fibre tip and the
vein wall prevent vessel wall ulceration, perforation and
perivenous tissue destruction? Uniformity of vein wall
destruction was compared in veins treated with a normal
bare fibre and veins treated with the tulip catheter.
Materials and Methods
Materials and techniques
Our investigation was approved by the ethics committee for
animal experiments at the Catholic University of Leuven,
Belgium. Goat saphenous veins were used since the lateral
saphenous vein has amean diameter of 4e6 mm in the supine
position, which is comparable to human veins (Fig. 2).
In 10 goats, 20 lateral saphenous veins were treated with
EVLA. The goats were treated under general anaesthesia.
Under ultrasound control (Terason t 3000 laptop ultra-
sound, Teratech, Burlington, USA) access was obtained by
a puncture in the distal part of the lateral saphenous vein.
A sheath was introduced and the fibre (600 mm) was placed
near the saphenofemoral junction. Physiological saline (at
22 C) was injected abundantly around the saphenous vein
inducing spasm of the vein and acting as a protective
barrier to the perivenous tissue. We injected, on average,
134 ml of liquid around the target veins, equivalent to
9.2 ml cme1. Ten veins were treated using a normal bare
fibre (group 1), the remaining 10 using the new tulip-sha-
ped, self-expandable catheter (group 2). Veins were
treated with a 980 nm diode laser (Inter-Medic, Barcelona,
Spain), using a continuous pullback protocol. Power was set
to 8 W and pullback speed was adjusted to deliver a linear
endovenous energy density (LEED)17 between 60 and
65 J cme1.able catheter fixed to the fibre.
Figure 2 The lateral saphneous vein in a goat.
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Postoperatively, the veins were completely surgically
removed, including perivenous tissue, at intervals following
treatment. Six veins were removed immediately, eight
veins after 10 days and six veins after 3 weeks. Excised
veins were prepared for histological examination. About
11e15 sections of each of these veins were taken at
random.
The pathologists measured the diameter and the depth
of ulceration in the vein wall using a range of magnifica-
tions. Each optical field correlates with a constant defined
diameter. Eyepiece graticules were used for measurement
of the specimens. The perivenous tissue destruction wasFigure 3 Perivenous tissue destruction scale: the perivenous d
between the edge of the outer vein wall and the surrounding fascquantified using a scoring system (Fig. 3) devised for this
study, as described below.
Description of the fibre-tip catheter: tulip catheter
The fibre-tip centring catheter (Tobrix, Waalre, the
Netherlands) consists of a hollow tube, fixed to the laser
fibre. This tube has tulip-shaped, self-expandable blades at
its distal end (around the fibre tip). The tube is folded into
an outer guiding catheter, which permits easy access to the
vein undergoing treatment. When the outer guiding cath-
eter is withdrawn (pullback), the tulip-shaped blades at
the distal end of this tube expand and push the vein wallestruction is measured at three points (A,B,C). The distance
ia is divided into three parts (1,2,3).
Table 1 Histological data of veins immediately removed
after treatment. Group 1: without catheter. Group 2: with
tulip-catheter.
none ulceration perforation depth
Group 1 nZ 3
Sections: 39
nZ 7 nZ 7 nZ 25 0.51 mm
(SD:0.23)
Group 2 nZ 3
Sections: 39
nZ 39 nZ 0 nZ 0 0
Figure 4 Vein treated without catheter showing ulcerations
and carbonisation at the point of direct contact.
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luminally and prevents direct contact with the vein wall
(Fig. 1).
The catheter is made from PEEK, an organic polymer,
semi-crystalline thermoplastic, with a melting point around
343 C (662 F).14 It is highly resistant to thermal degrada-
tion as well as attack by both organic and aqueous envi-
ronments. It is considered an advanced biomaterial used in
medical implants.15,16 PEEK has excellent mechanical and
chemical resistance properties that are retained to high
temperatures. This catheter is referred to below as the
tulip catheter.
Perivenous tissue destruction scale (Fig. 3)
The lateral saphenous vein in a goat is surrounded by
a triangle-shaped fascia. At three different points at the
edge of the vein, located 120 apart, the perivenous tissue
destruction was measured. The distance between the vein
wall and the surrounding fascia was divided into three
equal layers. The extent of necrosis was graded following
the scale: 0Z no necrosis, 1Z necrosis. Consequently, at
each location, if the three layers were involved, the extent
of necrosis was graded 3. Each part where necrosis is seen
was scored 1. Consequently, if the necrosis was seen in all
three positions, the maximum necrosis can reach a score
equal to 9. Perivenous tissue destruction was measured
immediately after treatment and then after 10 days and 3
weeks.
Measurements of perivenous temperature
The temperature in the perivenous fluid used to simulate
tumescent anaesthesia was measured using thermocou-
ples (thermocouple type K, Pronto tc, Thermo-Electric,
Balen, Belgium). One needle was inserted at the proximal
and another at the more distal part of the vein. The
location of the needle in the perivenous liquid in the
immediate proximity of the vein wall was checked by
perioperative ultrasound. The thermocouples were con-
nected to a digital thermometer (Pronto tc, Thermo-
Electric, Balen, Belgium). Temperature was measured
during fibre withdrawal to determine the maximum
temperature for both the groups (with and without tulip
catheter).
Statistical evaluation
Statistical analysis was performed using SPSS 16.0 (Statis-
tical Package for the Social Sciences; SPSS Inc., Chicago,
IL, USA). Inter-group variances for unpaired continuous
and ordinal data were evaluated non-parametrically using
the Student’s t-test. An a-level of significance of 0.05 was
used.
Results
Ten goats were treated according to the protocol described
above. The mean diameter of the veins was 0.47 cm (SD:
0.08 cm) measured in the supine position. LEED was64.3 J cme1 in group 1 (bare fibre) versus 60.2 J cme1 in
group 2 (not statistically different).
A temperature increase around the treated vein (in the
tumescent liquid) was observed during fibre pullback. On
average, the maximum temperature was 50 C (min:
32.3 C; max: 68.3 C) without using the catheter and 47 C
(min: 34.1 C; max: 80 C) using the tulip catheter. These
differences were not statistically significant (p> 0.05).
Six veins were removed immediately after treatment
(Table 1). In three of them, the new tulip catheter was used
(group 2). In both the groups, 39 sections were taken for
histological analysis.
In the veins treated without the tulip catheter (group 1),
an uneven destruction of the vein wall was seen, with
ulceration and perforation. Very limited perivenous
tissue destruction was seen at the point of perforation.
Carbonisation was found at the point of direct contact
(Fig. 4). Veins treated using the tulip catheter (group 2)
did not show any ulceration or perforation. The vein wall
looked normal. Only a limited amount of carbonisation was
found intraluminally. The intraluminal blood was dena-
tured probably due to boiling. No perivenous tissue
destruction was seen. The extent of ulceration and
perforation was significantly different between the two
groups.
Veins harvested 10 days after treatment (nZ 8)(Table
2) showed, in both the groups, a cell-rich necro-inflam-
matory process surrounding the treated vein. This newly
Table 2 Histological data of veins harvested 10 days after treatment. Group 1: without catheter. Group 2: with tulip-catheter.
none ulceration perforation depth Circumferential
destruction
PVDS
Group 1 nZ 4 Sections: 44 nZ 19 nZ 11 nZ 14 0.5 SD: 0.35 64% SD: 24 3.8 SD: 2.1
Group 2 nZ 4 Sections: 55 nZ 53 nZ 2 nZ 0 0.02 SD: 0.07 80% SD: 26 1.7 SD: 1.9
PVDS: perivenous tissue destruction scale.
Table 3 Histological data of veins harvested 3 weeks after
treatment. Group 1: without catheter. Group 2: with
tulip-catheter.
Circumferential destruction PVDS
Goup 1 nZ 3
sections: 43
79% SD: 28 2.1 SD: 2.1
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small vessels with migration of fibroblasts and phagocytes.
The destruction of the vein wall was far more extensive
than was seen in the sections of the veins removed
immediately after treatment: major parts of the vein wall
were destroyed and the muscle cells were necrotic
(Fig. 5). Perivenous tissue destruction could be seen andFigure 5 Veins harvested 10 days after treatment. a: Vein
treated without catheter showing an ulcer with perivenous
tissue destruction especially at the point of direct contact
(ulcer). The transmural vein wall necrosis takes 67% of the
total circumference(arrow). b: Vein treated using tulip cath-
eter showing a more circumferential vein wall destruction.
Notice the infiltration of the vein wall by macrophages and
necro-inflammatory cells.
Group 2 nZ 3
sections: 45
98% SD: 8.7 2.0 SD: 1.9
PVDS: perivenous tissue destruction scale.this especially at the points of direct contact between the
fibre and the vein wall.
The use of the tulip catheter almost completely elimi-
nated ulceration and perforation after EVLA.
Transmural destruction of the vein wall, with complete
necrosis of the muscle cells, is expressed as a percentage of
the total circumference of the vein wall. We found, on
average, 64% (SD: 24) and 80% (SD: 26) circumferential vein
wall necrosis, respectively (pZ 0.02). The mean peri-
venous destruction score was of 3.8 (SD: 2.1) in the bare
fibre group versus 1.7 (SD:1.8) for the tulip catheter group
(pZ 0.01).
Three weeks postoperatively (Table 3), six veins were
harvested. Organisation in and around the vein walls was
very extensive. The inflammatory tissue was infiltrating
the treated veins. Newly formed small vessels around the
treated veins were accompanied by macrophages and
histiocytes, removing the destroyed tissue and forming
scar tissue. At the points of perforation in the vein wall,
there was deeper destruction of the perivenous tissue
(Fig. 6). At these points, we found more carbonisation,
which in some cases was encapsulated by polynuclear
leucocytes. This perivenous tissue destruction in some
cases was clearly in regression due to the healing
process. The intraluminal content was mostly damaged
with eosinophilic denaturation of the intravascular
material. Major parts of the vein wall were destroyed and
the muscle cells were necrotic, but sometimes in an
uneven distribution . Some parts were not destroyed or
incompletely destroyed; the remaining vein wall encap-
sulated the destroyed part by forming a new endothelial
layer on the opposite side, forming a new lumen which
might lead to recanalisation (Fig. 7). The exact border of
the ulceration was often difficult to establish. More
complete circumferential destruction was observed in the
tulip catheter group (Table 3). There was no significant
difference in measurements of perivenous destruction. In
some cases, we found regression of perivenous inflam-
mation due to the healing process and formation of scar
tissue.
Figure 7 Vein removed three weeks(without catheter) after
treatment showing a recanalisation at a point where the vein
wall has not been sufficiently destroyed. Circumferential vein
wall destruction takes 70% (arrow).
Figure 6 Veins removed three weeks after treatment. a:
Vein treated without catheter showing a complete circumfer-
ential vein wall destruction. Carbonisation at the point of
direct contact. b: Vein treated using the tulip catheter.
Complete circumferential vein wall necrosis.
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EVLA of the incompetent saphenous vein is safe and is at
least as effective as surgery.1e5 Complications include
postoperative ecchymosis, pain and periphlebitis, and
recanalisation may occur in incompletely treated
veins.8,18,19 By centring the fibre intraluminally and
avoiding direct contact between the fibre tip and the vein
wall, we examined whether morphological causes of
postoperative complications could be prevented. The
tulip catheter minimised ulceration and perforation of
the vein wall. Veins removed immediately after treat-
ment showed no perforation and only infrequent ulcera-
tion when the tulip catheter was used. The vein wall
appeared to be untouched. We believe that prevention of
vein wall perforation will lead to less postoperative
ecchymosis.
Veins removed 10 days after treatment showed greater
circumferential vein wall destruction compared with the
group in which the bare fibre was used. This proves that the
direct contact between the fibre and the vein wall is not
the most significant mode of action of EVLA. In fact, direct
contact is responsible for the ulceration and perforation
due to the convection of heat energy from the fibre tip into
the surrounding tissue7,13 and should be avoided if possible.
Energy leakage through the perforations is responsible for
perivenous tissue destruction and inflammation.7 We found
greater perivenous tissue destruction score with the bare
fibre. However, the temperature rise in the perivenous fluid
did not differ significantly in the two groups, but there was
a wide range of measurement. This is probably due to the
position of the thermocouple. If the needle is positioned
very near the vein wall a large temperature rise was found,
but if the needle tip was positioned some millimetres away
from the vein wall the temperature rise was much more
limited.
The extent of vein wall destruction and perivenous
tissue destruction cannot be assessed in veins harvested
immediately after treatment, but only in samples
removed later.7 Absorption is the primary event that
allows a laser or other light source to cause a potentially
therapeutic (or damaging) effect on a tissue. If the
temperature rises above 42 C, protein denaturation
starts. Due to the transformation of light energy into
thermal energy, the temperature in and around the
treated veins rises.20,21 The vein wall cells are heated and
their intracellular proteins denature and the cells become
necrotic. This cannot be detected histologically until
sufficient time has elapsed to allow inflammatory and
tissue repair processes to begin.
Three weeks postoperatively, vein wall destruction is
even more extensive and the organisation of destroyed
tissue into scar tissue becomes very clear . The peri-
venous inflammatory tissue is in regression and the per-
ivenous tissue destruction is more demarcated in both
the groups. Necrotic cells have been eliminated by the
inflammatory cells and the macrophages and fibrotic
tissue is formed. So the advantage in using the tulip
catheter in reducing the perivenous tissue destruction
and the secondary appearance of inflammatory tissue is
time limited. The appearance of the perivenous
116 M. Vuylsteke et al.inflammation may correlate with the clinically found
‘periphlebitis’. This is a common complication of EVLA
and is defined as a burning sensation around the treated
vein. It usually starts on the fifth postoperative day. Its
intensity and duration are variable, and this uncomfort-
able burning sensation improves with the intake of anti-
inflammatory drugs.
In some veins, we found the formation of a new lumen
when the vein wall had been partially destroyed. On the
opposite side of the vein a new endothelial layer was
formed, and this could result in recanalisation. It is not
known whether this segmental formation of a new lumen
clinically will result in a recanalisation, but if major parts of
the vein wall remain undamaged it is likely. Since the use of
the tulip catheter results in more even vein wall destruc-
tion, a higher occlusion rate might be expected.
The lateral saphenous vein in goats has been used as
a venous model in the previous work in this field.7,22 These
are not varicose veins and the thickness of the vein wall is
therefore somewhat smaller than that of human varicose
veins. Whilst this is a useful model it does not replicate
human varicose saphenous veins.
Conclusion
EVLA using a new tulip-shaped, self-expandable catheter
fixed to the fibre minimises ulceration and perforation in the
treated vein. It also results in a more even circumferential
vein wall necrosis and less perivenous tissue destruction. We
believe that thismay result in less postoperative ecchymosis,
pain, periphlebitis and possibly a higher occlusion rate when
used for the management of varicose veins. These hypoth-
eses require investigation in clinical studies.
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